DDR

Votiro Delivers Strong Customer and Partner Momentum in 2024

Retrieved on: 
Thursday, May 2, 2024
Software, Internet, Hardware, Artificial Intelligence, Data Management, Technology, Online Privacy, Security, ARR, RSA Conference, GTM, Partnership, Conference, Gen, OneDrive, Intelligence, Product management, Microsoft, DDR

Votiro DDR brings real-time monitoring, cyber threat prevention, and automated mitigation for continuous compliance for mid-sized enterprises.

Key Points: 
  • Votiro DDR brings real-time monitoring, cyber threat prevention, and automated mitigation for continuous compliance for mid-sized enterprises.
  • Last year, the company unveiled a revamped partner program , the Votiro Accelerate Partner Program, and launch of the Votiro MSP Dashboard, which has been a critical step in improving the business partner experience.
  • This year, Votiro was listed in the CRN Partner Program Guide, highlighting new features in the expanded partner program.
  • Contact us if you want to chat more about the evolution of the data security market, Votiro DDR or partnership opportunities.

New Data Shows Q1 UK Mortgage Arrears Growth Slows to Lowest Since Mini-Budget

Retrieved on: 
Monday, April 29, 2024
Technology, Personal Finance, Finance, Fintech, Banking, Professional Services, Data Analytics, Asset Management, Data Management, Growth, Pressure, DDR, News, Ageing, Bank

The percentage of mortgages in arrears across Pepper Advantage’s UK portfolio grew by 3.9% in Q1 2024 compared to Q4 2023.

Key Points: 
  • The percentage of mortgages in arrears across Pepper Advantage’s UK portfolio grew by 3.9% in Q1 2024 compared to Q4 2023.
  • This figure compares to a quarterly growth rate of 5.7% in Q4 2023 and 7.0% in Q3 2023.
  • While the rate of arrears growth has slowed, the absolute rate of arrears remains at the highest level since 2008.
  • However, every age group saw lower growth in the arrears rate in Q1.

Forcepoint Introduces AI-Based DSPM to Deliver Real-time Visibility and Risk Remediation for Data Everywhere

Retrieved on: 
Tuesday, April 23, 2024
Data Management, Security, Technology, VoIP, Software, Artificial Intelligence, Internet, Organization, Roger Hawkins (drummer), Architecture, Forcepoint, Risk, Policy, PII, ROT, Theft, Platform as a service, Artificial intelligence, Box (company), Infrastructure as a service, Software as a service, Confluence, Risk management, Benefit, Microsoft, Classification, Privacy, DDR, Intellectual property, RSA, Cloud database, BYOD, Cryptocurrency

Forcepoint DSPM harnesses innovative AI-mesh technology to swiftly identify data risks, such as obsolescence, improper access, and misplaced files.

Key Points: 
  • Forcepoint DSPM harnesses innovative AI-mesh technology to swiftly identify data risks, such as obsolescence, improper access, and misplaced files.
  • Forcepoint addresses these issues by bringing together innovations such as DSPM with Forcepoint DLP into a unified data security solution.
  • Using Forcepoint Data Security solutions, growing businesses can enhance productivity through faster and safer data access and sharing for better innovation and collaboration.
  • Forcepoint DSPM, powered by Getvisibility, is immediately available direct from Forcepoint and through the company’s global network of channel partners.

Labelmaster's DGeo Packaging Division Adds Action Wood 360 Collapsible Wood Crates to Portfolio

Retrieved on: 
Tuesday, April 16, 2024
Other Transport, Packaging, Transport, Manufacturing, Alternative Energy, Energy, Logistics, Supply Chain Management, Retail, UN, Lithium, CMAS, Dangerous goods, DDR, Nail, Multimedia, Cargo

DGeo , the Packaging Division at Labelmaster , today announced that it has expanded its large-format lithium battery packaging solutions by introducing a line collapsible, clippable wooden crates.

Key Points: 
  • DGeo , the Packaging Division at Labelmaster , today announced that it has expanded its large-format lithium battery packaging solutions by introducing a line collapsible, clippable wooden crates.
  • View the full release here: https://www.businesswire.com/news/home/20240416666946/en/
    Obexion MAX wooden crates provide collapsible, clippable packaging solutions for safely transporting large lithium batteries.
  • (Photo: Business Wire)
    Produced by Action Wood 360 , Obexion MAX crates are easy to assemble and disassemble by simply snapping and unsnapping the wood pieces together with Clip-Lok metal clips—no screws, bolts or nails required.
  • “Shipping large lithium batteries safely requires strong, durable and proven packaging,” said Randy Blaylock, vice president business development, Action Wood 360.

Rivos Raises More Than $250M Targeting Data Analytics and Generative AI Markets

Retrieved on: 
Tuesday, April 16, 2024
Data Management, Technology, Manufacturing, Professional Services, Semiconductor, Security, Data Analytics, Software, Artificial Intelligence, Engineering, Hardware, CPU, TSMC, DDR DRAM, HBM, Capital, GPGPU, Silicon, Intel Capital, Research, Life, Synthetic media, CIDC, DDR, Memory, Generative, Data, MediaTek, Video game

Rivos , a RISC-V accelerated platform company targeting data analytics and Generative AI, announced it has raised more than $250M in its oversubscribed Series A-3 funding round, and Matrix Capital Management, the largest investor in this round, has joined the Board represented by Romit Shah.

Key Points: 
  • Rivos , a RISC-V accelerated platform company targeting data analytics and Generative AI, announced it has raised more than $250M in its oversubscribed Series A-3 funding round, and Matrix Capital Management, the largest investor in this round, has joined the Board represented by Romit Shah.
  • “The rapid changes in LLMs and the merger with the data analytics stack makes it vital that accelerators be easy to program and debug, and that data can seamlessly move between CPU and accelerator.
  • Rivos addresses this need through our recompile-not-redesign approach,” said Puneet Kumar, co-founder and CEO of Rivos.
  • “The Rivos team has adeptly integrated the groundbreaking new RISC-V architecture with an inventive accelerator, effectively bringing this vision to life.

Sentra Expands Advisory Board with Appointment of Cybersecurity Veteran Robert Bigman

Retrieved on: 
Tuesday, April 16, 2024
DAG, United Nations, Central Intelligence Agency, McDonald's, AI, CISO, LLM, Big man, Moscone Center, United, DDR, Defence Intelligence Agency (India), RSAC, Organization, CIA, Cryptocurrency

NEW YORK, April 16, 2024 /PRNewswire/ -- Sentra, a leader in cloud-native data security, today announced that the company has appointed Robert Bigman, cybersecurity consultant and former chief information security officer (CISO) at the Central Intelligence Agency (CIA), to its advisory board. Bigman brings more than 30 years of experience as a pioneer and expert in the protection of classified data and will advise Sentra on its ongoing mission to protect data, no matter where it travels, against constantly emerging cyber threats.

Key Points: 
  • NEW YORK, April 16, 2024 /PRNewswire/ -- Sentra , a leader in cloud-native data security, today announced that the company has appointed Robert Bigman , cybersecurity consultant and former chief information security officer (CISO) at the Central Intelligence Agency (CIA), to its advisory board.
  • More recently, Sentra announced Sentra Jagger , the industry's first Large Language Model (LLM)-assistant for cloud data security.
  • Bigman's appointment as advisor expands Sentra's U.S. presence and ensures the company's alignment with industry demands and standards around data-centric security.
  • "Having deep experience fortifying cyber defenses against elite hackers and cultivating robust cybersecurity frameworks for sustainable protection, Robert brings an unmatched perspective to Sentra's advisory board," said Yoav Regev, co-founder and CEO of Sentra.

Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024

Retrieved on: 
Wednesday, April 10, 2024
DNA replication, PARP1, Olaparib, PARG, CRISPR, PARP, HR, IC50, ADME, DNA, Chromatin, PDD, San Diego Convention Center, FEN1, DNA repair, DDR, EC50, Blacksmith, Niraparib, Erosion (morphology), AACR, ATR, Drug discovery, USP1, SAN, Pharmaceutical industry

"Using our metalloenzyme fragment-based drug discovery approach, we have identified a highly potent and selective inhibitor of FEN1 having synergies with multiple DDR drug classes that include inhibitors of PARP, PARG, USP1, and ATR."

Key Points: 
  • "Using our metalloenzyme fragment-based drug discovery approach, we have identified a highly potent and selective inhibitor of FEN1 having synergies with multiple DDR drug classes that include inhibitors of PARP, PARG, USP1, and ATR."
  • The Blacksmith fragment-based drug discovery platform identified a novel metal-binding pharmacophore that binds to the two magnesium ions in the FEN1 active site.
  • Further elaboration using fragment growth strategies resulted in highly potent and selective inhibitors.
  • Title: "Small molecule inhibitor of FEN1 nuclease utilizing a novel metal binding pharmacophore synergizes with inhibitors of USP1, PARP, PARG and ATR"

Americase to Showcase Leading Li-Ion Battery Shipping and Storage Solutions at Data Center World 2024

Retrieved on: 
Wednesday, April 10, 2024
Lithium, Ecosystem, Safety, Outline, OEM, Transport, Data, DDR, Movement, BBU, Electric battery

WAXAHACHIE, Texas, April 10, 2024 /PRNewswire/ -- Americase (booth #519), leading manufacturer of protective containers for hazmat and high value goods, will showcase the latest lithium-ion battery shipping and storage solutions, custom-engineered to meet the specific needs of data centers and their OEM partners during Data Center World, April 15-18 in Washington, D.C.

Key Points: 
  • WAXAHACHIE, Texas, April 10, 2024 /PRNewswire/ -- Americase (booth #519), leading manufacturer of protective containers for hazmat and high value goods, will showcase the latest lithium-ion battery shipping and storage solutions , custom-engineered to meet the specific needs of data centers and their OEM partners during Data Center World, April 15-18 in Washington, D.C.
  • "With the increasing reliance on lithium-ion batteries within the data center ecosystem, it's crucial to prioritize safety and compliance without sacrificing efficiency," said Robby Kinsala, CEO of Americase.
  • "Americase is committed to delivering solutions that not only meet but exceed these requirements, ensuring that data centers and their partners are well-prepared for the future."
  • Americase's participation in Data Center World 2024 underscores its commitment to innovation and excellence in the field of protective containment solutions.

Artios Pharma Bolsters Board of Directors with Appointment of Chris Liu, PhD

Retrieved on: 
Tuesday, April 9, 2024
Biotechnology, Kite, Business, Business administration, Patient, Research, DNA, Fudan University, Acquisition, NYU, MBA, Doctor of Philosophy, DDR, Master of Business Administration, Therapy, Drug development, Investment, RTW

CAMBRIDGE, United Kingdom and NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Artios Pharma Limited (“Artios”), clinical-stage biotech company led by pioneers of DNA damage response (“DDR”) drug development, announces the appointment of Chris Liu, Ph.D., Senior Research Analyst specializing in oncology at RTW Investments, LP (“RTW”), to its Board of Directors.

Key Points: 
  • CAMBRIDGE, United Kingdom and NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Artios Pharma Limited (“Artios”), clinical-stage biotech company led by pioneers of DNA damage response (“DDR”) drug development, announces the appointment of Chris Liu, Ph.D., Senior Research Analyst specializing in oncology at RTW Investments, LP (“RTW”), to its Board of Directors.
  • Niall Martin, Chief Executive Officer of Artios, said: “We are delighted to welcome Chris, a prominent research analyst to our Board of Directors.
  • Chris Liu, Ph.D. Board Director of Artios, added: “RTW is now a top shareholder of Artios following the acquisition of Arix and the expansion of our equity interest, which reflects both our confidence and excitement in Artios’ innovative platform targeting broad aspects of the DNA damage response.
  • He currently serves on the board of NiKang Therapeutics, Oricell Therapeutics and Nuance Pharma as a Board Director or Observer.

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

Retrieved on: 
Tuesday, March 26, 2024
Ovarian cancer, Cyclin, IND, Therapy, Anemia, Research, University, Cell cycle, MD Anderson Cancer Center, PLK1, DDR, Investigational New Drug, Safety, Pharmacokinetics, Synthetic lethality, WEE1, U.S. FDA, Mutation, Acceleration, Part, HERG, ATR, KOL, Acquisition, Cancer, AACR, Research and development, Poster, FDA, Cyclin E, Toxicity, Aplastic anemia, Administration, Conference, APRE, PLK3, PLK2, Division, Data, Cardiotoxicity, Pharmaceutical industry

DOYLESTOWN, Pa., March 26, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.

Key Points: 
  • “Aprea had a very productive 2023 with significant progress across our diversified pipeline of synthetic lethality-based cancer therapeutics.
  • An update from Part 1 of the trial was featured in a poster presentation at the AACR-NCI-EORTC International Conference in October 2023.
  • Select Financial Results for the Fourth Quarter ended December 31, 2023
    As of December 31, 2023, Aprea reported cash and cash equivalents of $21.6 million.
  • Research and Development (R&D) expenses were $2.0 million for the quarter ended December 31, 2023, compared to $0.5 million for the fourth quarter of 2022.